FMC - Oceana is a medicare approved dialysis facility center in Oceana, West Virginia and it has 12 dialysis stations. It is located in Wyoming county at 1777 Cook Parkway, Oceana, WV, 24870. You can reach out to the office of FMC - Oceana at (304) 682-5371. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Oceana has the following ownership type - Profit. It was first certified by medicare in November, 2010. The medicare id for this facility is 512536 and it accepts patients under medicare ESRD program.
| Name | FMC - Oceana |
|---|---|
| Location | 1777 Cook Parkway, Oceana, West Virginia |
| No. of Dialysis Stations | 12 |
| Medicare ID | 512536 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1777 Cook Parkway, Oceana, West Virginia, 24870 | |
| (304) 682-5371 | |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
| NPI Number | 1710201348 |
| Organization Name | Fresenius Medical Care Oceana |
| Doing Business As | Bio-medical Applications Of West Virginia Inc |
| Address | 1777 Cook Parkway Oceana, West Virginia, 24870 |
| Phone Number | (304) 682-5371 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 15 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 15 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 126 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 5 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Oceana with elevated calcium levels.
| Patients with hypercalcemia | 24 |
| Hypercalcemia patient months | 200 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 29 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 33 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 43 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 11 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 23 |
| Patient months included in arterial venous fistula and catheter summaries | 162 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 60 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 22 |
| Hospitalization Rate in facility | 271.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 536.7 |
| Hospitalization Rate: Lower Confidence Limit | 144.6 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Oceana were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.1 |
| Readmission Rate: Lower Confidence Limit | 20 |
News Archive
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles. The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. The system detects obstacles - even those overhead - by scanning the depth of its surroundings, taken from two different angles - similar to that of the human eye.
The Associated Press: "Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released recommendations Tuesday night designed to improve oversight of the U.S. device industry, including the government's ability to revoke approval for products that prove unsafe or ineffective" (Perrone, 8/3).
Michelle A. Williams, Sc.D., co-director and principal investigator at the Center for Perinatal Studies at Swedish Medical Center in Seattle and Professor of Epidemiology and Global Health at the University of Washington, has received two grants totaling $5.6 million for research into complications affecting pregnancy.
› Verified 3 days ago